IBDEI0OD ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10858,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,10859,0)
 ;;=J9035^^76^708^2^^^^1
 ;;^UTILITY(U,$J,358.3,10859,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10859,1,2,0)
 ;;=2^Bevacizumab 10mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10859,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,10860,0)
 ;;=J0178^^76^708^1^^^^1
 ;;^UTILITY(U,$J,358.3,10860,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10860,1,2,0)
 ;;=2^Aflibercept 1mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10860,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,10861,0)
 ;;=J7312^^76^708^5^^^^1
 ;;^UTILITY(U,$J,358.3,10861,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10861,1,2,0)
 ;;=2^Dexamethasone Intra Implant
 ;;^UTILITY(U,$J,358.3,10861,1,3,0)
 ;;=3^J7312
 ;;^UTILITY(U,$J,358.3,10862,0)
 ;;=J3301^^76^708^15^^^^1
 ;;^UTILITY(U,$J,358.3,10862,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10862,1,2,0)
 ;;=2^Triamcinolone Acetonide per 10mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10862,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,10863,0)
 ;;=J2778^^76^708^9^^^^1
 ;;^UTILITY(U,$J,358.3,10863,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10863,1,2,0)
 ;;=2^Ranibizumab per .01mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10863,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,10864,0)
 ;;=C9257^^76^708^3^^^^1
 ;;^UTILITY(U,$J,358.3,10864,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10864,1,2,0)
 ;;=2^Bevacizumab 0.25mg (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10864,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,10865,0)
 ;;=67028^^76^709^1^^^^1
 ;;^UTILITY(U,$J,358.3,10865,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10865,1,2,0)
 ;;=2^INTRAVITREAL EYE INJ-1 Eye/Unilateral
 ;;^UTILITY(U,$J,358.3,10865,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,10866,0)
 ;;=J3301^^76^709^7^^^^1
 ;;^UTILITY(U,$J,358.3,10866,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10866,1,2,0)
 ;;=2^Triamcinolone/KENALOG (use w/ 68200)
 ;;^UTILITY(U,$J,358.3,10866,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,10867,0)
 ;;=J0178^^76^709^2^^^^1
 ;;^UTILITY(U,$J,358.3,10867,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10867,1,2,0)
 ;;=2^Aflib/EYLEA (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10867,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,10868,0)
 ;;=J7312^^76^709^14^^^^1
 ;;^UTILITY(U,$J,358.3,10868,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10868,1,2,0)
 ;;=2^Dexameth Implant/OZURDEX
 ;;^UTILITY(U,$J,358.3,10868,1,3,0)
 ;;=3^J7312
 ;;^UTILITY(U,$J,358.3,10869,0)
 ;;=J3300^^76^709^8^^^^1
 ;;^UTILITY(U,$J,358.3,10869,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10869,1,2,0)
 ;;=2^Triamcinolone/TRIESENCE (use w/ 67028)
 ;;^UTILITY(U,$J,358.3,10869,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,10870,0)
 ;;=64612^^76^709^10^^^^1
 ;;^UTILITY(U,$J,358.3,10870,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10870,1,2,0)
 ;;=2^Chemodenervation of Muscle Inj (eg,Botox),Unilat
 ;;^UTILITY(U,$J,358.3,10870,1,3,0)
 ;;=3^64612
 ;;^UTILITY(U,$J,358.3,10871,0)
 ;;=68200^^76^709^6^^^^1
 ;;^UTILITY(U,$J,358.3,10871,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10871,1,2,0)
 ;;=2^Subtenons Injection
 ;;^UTILITY(U,$J,358.3,10871,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,10872,0)
 ;;=67505^^76^709^15^^^^1
 ;;^UTILITY(U,$J,358.3,10872,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,10872,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,10872,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,10873,0)
 ;;=67500^^76^709^16^^^^1
 ;;^UTILITY(U,$J,358.3,10873,1,0)
 ;;=^358.31IA^3^2
